Concepedia

Peter Sawan

PS

Statistics

Publications

12

Citations

865

H-Index

11

Active since

2013

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

University of Cagliari

SDN Istituto di Ricerca Diagnostica e Nucleare

Istituti di Ricovero e Cura a Carattere Scientifico

Peter Sawan is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and immunotherapy.

ORCID

Publications per year

2013–2023

12

Publications

12

Clinical and molecular correlates of PD-L1 expression in patients with lung adenocarcinomas

A.J. Schoenfeld, H. Rizvi, Chai Bandlamudi et al. · Annals of Oncology · 2020 · 341 citations · Full text

, , +16

Lesion-Level Response Dynamics to Programmed Cell Death Protein (PD-1) Blockade

Juan C. Osorio, Kathryn C. Arbour, Dung T. Le et al. · Journal of Clinical Oncology · 2019 · 134 citations · Full text

, , +17

Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamics

Laura Mezquita, Isabel R. Preeshagul, Édouard Auclin et al. · European Journal of Cancer · 2021 · 60 citations · Full text

, , +12

Prospective testing of clinical Cerenkov luminescence imaging against standard-of-care nuclear imaging for tumour location

Edwin C. Pratt, Magdalena Skubal, Benedict Mc Larney et al. · Nature Biomedical Engineering · 2022 · 60 citations · Full text

, , +11

Outcomes to first-line pembrolizumab in patients with PD-L1-high (≥50%) non–small cell lung cancer and a poor performance status

Joao V. Alessi, Biagio Ricciuti, E. Jimenez-Aguilar et al. · Journal for ImmunoTherapy of Cancer · 2020 · 58 citations · Full text

, , +17

1–5 of 12